跳至主要内容
临床试验/JPRN-jRCT2080221303
JPRN-jRCT2080221303未知3 期

KRP-108 comparative study(Phase III clinical trial) - active controlled, single blinded, comparative study in adult asthmatic subjects

Kyorin Pharmaceutical Co.,LTD0 个研究点开始时间: 2010年11月10日最近更新:
适应症

试验速览

阶段
3 期

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 16age old 至 ot applicable(—)
性别
All

入选标准

  • Patients treated with ICS(less than 400ug/day fluticasone propionate conversion) during 4 weeks before Visit1
  • -Patients whose FEV1.0 indicate within the certain definite range of predicted FEV1.0
  • -Out patients
  • And others.

排除标准

  • -Patients who have previous/concurrent disease of malignant tumor
  • -Patients who have lung infection currently
  • -Patients treated with systemic steroids during 4 weeks before Visit1
  • -Patients who have irreversible lung disease such as pulmonary fibrosis

研究者

相似试验

KRP-108 comparative study | 临床试验